Last Price$40.7(9.8%)
Market Cap$9,261.6M
LTM Net Change in Cash
$123.9M
YoY Growth
+148.4%
3Y CAGR
+40.9%
5Y CAGR
N/A
Stock quality & Intrinsic value
7/10
45.4% overvalued
Hims & Hers Health, Inc. Net Change in Cash
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
| Net Change in Cash | $20.8M | ($18.9M) | $5,553.0K | $44.3M | ($25.0M) | $49.9M |
Overvalued or undervalued?
Check the intrinsic value for HIMS
and see if it's the right time to invest.
Hims & Hers Health, Inc. (HIMS) Net Change in Cash comparison analysis
General
LTM Net Change in Cash
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Hims & Hers Health, Inc.HIMS
$123.9M
148.4%
40.9%
N/A
Median Peer Set
($69.5M)
0.0%
6.4%
0.0%
The Procter & Gamble CompanyPG
$2,340.0M
125.9%
N/A
(2.0%)
Church & Dwight Co., Inc.CHD
$619.6M
N/A
120.9%
N/A
Colgate-Palmolive CompanyCL
$130.0M
(31.9%)
N/A
(3.7%)
e.l.f. Beauty, Inc.ELF
($1,110.0K)
(90.8%)
(24.2%)
N/A
The Clorox CompanyCLX
($67.0M)
N/A
(50.2%)
N/A
Kimberly-Clark CorporationKMB
($72.0M)
N/A
29.7%
(5.8%)
Unilever PLCUL
($195.4M)
(84.7%)
49.6%
3.3%
Coty Inc.COTY
($214.9M)
N/A
71.2%
15.3%
Kenvue Inc.KVUE
($312.0M)
N/A
N/A
N/A
The Estée Lauder Companies Inc.EL
($1,353.0M)
N/A
12.8%
N/A
HIMS key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
% growth | 26.7 0.0% | 82.6 209.4% | 148.8 80.2% | 271.9 82.8% | 526.9 93.8% | 872.0 65.5% |
| Cost of Goods Sold (COGS) | 18.9 | 38.0 | 39.3 | 67.4 | 118.2 | 157.1 |
% margin | 7.8 29.2% | 44.6 54.0% | 109.5 73.6% | 204.5 75.2% | 408.7 77.6% | 714.9 82.0% |
| Operating Expenses | 83.6 | 119.0 | 124.6 | 319.5 | 477.4 | 744.4 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 11.2 | 22.4 | 29.2 | 48.2 |
| Selling, General & Administrative Expenses (SG&A) | 83.6 | 119.0 | 124.6 | 319.5 | 370.8 | 692.7 |
% margin | (75.8) (284.0%) | (74.4) (90.1%) | (15.1) (10.2%) | (115.0) (42.3%) | (68.7) (13.0%) | (29.5) (3.4%) |
| Interest Income | 0.6 | 1.9 | 0.4 | 0.4 | 2.6 | 0.0 |
| Interest Expense | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (75.2) | (72.0) | (18.0) | (110.8) | (65.7) | (21.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (0.1%) | 0.1 (0.7%) | (3.1) 2.8% | (0.0) 0.0% | 2.0 (9.2%) |
% margin | (75.2) (282.0%) | (72.1) (87.3%) | (18.1) (12.2%) | (107.7) (39.6%) | (65.7) (12.5%) | (23.5) (2.7%) |
| EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
| Diluted EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
% margin | 0.0 0.0% | (74.2) (89.8%) | (14.1) (9.5%) | (111.0) (40.8%) | (61.2) (11.6%) | (19.9) (2.3%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Hims & Hers Health, Inc.'s Net Change in Cash?
As of today, Hims & Hers Health, Inc.'s last 12-month Net Change in Cash is $123.9M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Hims & Hers Health, Inc.'s Net Change in Cash growth rate?
Over the last year, Hims & Hers Health, Inc.'s Net Change in Cash growth was 148.4%. The average annual Net Change in Cash growth rates for Hims & Hers Health, Inc. have been 26.4% over the past three years, N/A over the past five years.